Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis
ConclusionsVitD could serve as a prognosticator and potential therapeutic target in patients with IPF. Further studies are sorely needed.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Drugs & Pharmacology | Epidemiology | Hormones | Respiratory Medicine | Study | Vitamin D | Vitamin D Deficiency | Vitamins